Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice.

Neznanov N, Man AK, Yamamoto H, Hauser CA, Cardiff RD, Oshima RG.

Cancer Res. 1999 Sep 1;59(17):4242-6.

2.

Ets2-dependent microenvironmental support of mouse mammary tumors.

Tynan JA, Wen F, Muller WJ, Oshima RG.

Oncogene. 2005 Oct 20;24(46):6870-6.

PMID:
16007139
3.

Ets2-dependent stromal regulation of mouse mammary tumors.

Man AK, Young LJ, Tynan JA, Lesperance J, Egeblad M, Werb Z, Hauser CA, Muller WJ, Cardiff RD, Oshima RG.

Mol Cell Biol. 2003 Dec;23(23):8614-25.

4.

The role of the Ets2 transcription factor in the proliferation, maturation, and survival of mouse thymocytes.

Zaldumbide A, Carlotti F, Pognonec P, Boulukos KE.

J Immunol. 2002 Nov 1;169(9):4873-81.

5.

Ets transcription factors and targets in osteogenesis.

Raouf A, Seth A.

Oncogene. 2000 Dec 18;19(55):6455-63. Review.

6.

ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway.

Wolvetang EJ, Wilson TJ, Sanij E, Busciglio J, Hatzistavrou T, Seth A, Hertzog PJ, Kola I.

Hum Mol Genet. 2003 Feb 1;12(3):247-55.

PMID:
12554679
7.
9.

Ets2 is not required for Ras or Neu/ErbB-2 mediated cellular transformation in vitro.

Hevér A, Oshima RG, Hauser CA.

Exp Cell Res. 2003 Oct 15;290(1):132-43.

PMID:
14516794
10.

Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice.

Sumarsono SH, Wilson TJ, Tymms MJ, Venter DJ, Corrick CM, Kola R, Lahoud MH, Papas TS, Seth A, Kola I.

Nature. 1996 Feb 8;379(6565):534-7.

PMID:
8596630
12.

Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide.

Carbone GM, McGuffie EM, Collier A, Catapano CV.

Nucleic Acids Res. 2003 Feb 1;31(3):833-43.

13.

Mouse models in the study of the Ets family of transcription factors.

Bartel FO, Higuchi T, Spyropoulos DD.

Oncogene. 2000 Dec 18;19(55):6443-54. Review.

14.

Ets2 is expressed during morphogenesis of the somite and limb in the mouse embryo.

Ristevski S, Tam PP, Hertzog PJ, Kola I.

Mech Dev. 2002 Aug;116(1-2):165-8.

15.

Expression of the transcription factor ETS2 in brain of patients with Down syndrome--evidence against the overexpression-gene dosage hypothesis.

Greber-Platzer S, Schatzmann-Turhani D, Cairns N, Balcz B, Lubec G.

J Neural Transm Suppl. 1999;57:269-81.

PMID:
10666682
16.

Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis.

Wolvetang EJ, Bradfield OM, Hatzistavrou T, Crack PJ, Busciglio J, Kola I, Hertzog PJ.

Neurobiol Dis. 2003 Dec;14(3):349-56.

PMID:
14678752
17.
18.

In vivo modulation of ETS genes induced by electromagnetic fields.

Mucci N, Ianni A, Ursini CL, Arzani D, Bhat NK, Navarra P, Romano-Spica V.

In Vivo. 2001 Nov-Dec;15(6):489-94.

PMID:
11887334
19.
20.

Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene.

Kopp JL, Wilder PJ, Desler M, Kim JH, Hou J, Nowling T, Rizzino A.

J Biol Chem. 2004 May 7;279(19):19407-20. Epub 2004 Feb 19.

Supplemental Content

Support Center